Skip to content

Category: CambridgeSyndicate content

Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer

November 22, 2009

Cambridge, MA -- November 23, 2009 -- Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Projections of savings from health IT are baseless, Harvard researchers say

November 20, 2009

The increased computerization in U.S. hospitals hasn't made them cheaper or more efficient, Harvard researchers say, although it may have modestly improved the quality of care for heart attacks.

MIT: Better way to harness waste heat

November 18, 2009

CAMBRIDGE, Mass. - New MIT research points the way to a technology that might make it possible to harvest much of the wasted heat produced by everything from computer processor chips to car engines to electric powerplants, and turn it into usable electricity.

Ticking stellar time bomb identified

November 17, 2009

"One of the major problems in modern astrophysics is the fact that we still do not know exactly what kinds of stellar system explode as a Type Ia supernova," says Patrick Woudt, from the University of Cape Town and lead author of the paper reporting the results.

Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor

November 11, 2009

CAMBRIDGE, MA -- November 11, 2009 -- Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collabora

Orphan army ants join nearby colonies

November 4, 2009

Colonies of army ants, whose long columns and marauding habits are the stuff of natural-history legend, are usually antagonistic to each other, attacking soldiers from rival colonies in border dispute

Materials scientists find better model for glass creation

November 4, 2009

CAMBRIDGE, Mass. -- Harvard materials scientists have come up with what they believe is a new way to model the formation of glasses, a type of amorphous solid that includes common window glass.

Clinical tests begin on medication to correct Fragile X defect

November 2, 2009

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile

Poorly cleaned public cruise ship restrooms may predict norovirus outbreaks

November 2, 2009

(Boston) -- A team of researchers from Boston University School (BUSM), Carney Hospital, Cambridge Health Alliance and Tufts University School of Medicine, have found that widespread poor complian

For gay and straight men, facial attraction operates similarly

October 30, 2009

CAMBRIDGE, Mass., October 30, 2009 -- A new study from a researcher at Harvard University finds that gay men are most attracted to the most masculine-faced men, while straight men prefer the most

The pain of torture can make the innocent seem guilty

October 26, 2009

CAMBRIDGE, Mass., October 26, 2009 -- The rationale behind torture is that pain will make the guilty confess, but a new study by researchers at Harvard University finds that the pain of torture can

AGU Journal highlights -- Oct. 26, 2009

October 26, 2009

The following highlights summarize research papers that have been published or accepted for publication (paper in press) in Geophysical Research Letters (GRL).

Master regulator found for regenerating nerve fibers in live animals

October 25, 2009

Boston, Mass. -- Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.